Anatara Lifesciences Ltd

Last Updated:
10:23 am
Tuesday, July 8, 2025
Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. It also develops and commercializes Detach, a non-antibiotic therapy that prevents and treats diarrhea in piglets. The company was founded by Tracey Mynott on July 15, 2010 and is headquartered in Adelaide, Australia.
Market Cap
AU$1.07M
Volume
501110
Open
0.01
AU$
High
0.01
AU$
Low
0.01
AU$
Shares On Issue
196M
52 Week Low
0.004
AU$
52 Week High
0.073
AU$
Website
Sector
Healthcare
Pharmaceuticals: Major
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.